期刊文献+

卵巢癌中LPA受体、Bcl-2和Bax基因的表达和意义 被引量:8

EXPRESSION AND SIGNIFICANCE OF LYSOPHOSPHATIDIC ACID RECEPTORS,Bcl-2 AND Bax GENES IN OVARIAN CARCINOMAS
下载PDF
导出
摘要 目的研究溶血磷脂酸(lysophosphatidic acid,LPA)受体在人卵巢癌组织中基因的表达及意义,探讨LPA对人卵巢癌组织中Bcl-2和Bax基因表达的影响及意义。方法采用反转录聚合酶链反应法检测90例卵巢组织(包括正常卵巢组织、卵巢良性肿瘤组织、卵巢上皮癌组织)中LPA1、LPA2和LPA3基因的表达,分析LPA1、LPA2和LPA3基因表达与Bcl-2、Bax基因表达的相关性。结果在卵巢癌组织中LPA2和LPA3基因表达明显高于卵巢良性肿瘤和正常卵巢组织(P<0.05)。卵巢良性肿瘤和正常卵巢组织中LPA1基因表达明显高于卵巢癌组织(P<0.05)。LPA2和LPA3基因表达与Bcl-2基因表达呈显著正相关(r=0.308,P<0.01),与Bax基因表达呈显著负相关(r=-0.369,P<0.01)。结论LPA及其受体可能在卵巢癌的发生发展中起重要作用,LPA促进卵巢癌发展的机制之一可能是通过LPA2和LPA3影响Bcl-2和Bax表达,从而改变Bcl-2/Bax比例,抑制卵巢癌细胞的凋亡,促进卵巢癌的发展。 Objective To investigate: the expressions of lysophosphatidic acid (LPA) receptors at mRNA levels and their biological significance in different human ovarian epithelial ovarian neoplasms,and to study the relationship between the expressions of LPA1, LPA2, LPA3 genes and Bcl-2,Bax genes. Methods Reverse transcription-polymerase chain reaction(RT-PCR) was used to measure the expression levels of LPA1, LPA2, LPA3 and Bcl-2,Bax mRNA in normal ovary,ovarian benign tumor and ovarian cancer. Results LPA2 ,LPA3 and Bcl-2 expression ratios significantly increased in cancer, compared to those in non-cancerous state ( P 〈 0.05). Bax expression ratios significantly decreased in cancer compared to those in non-cancerous state( P 〈 0.05). A significant positive correlation in the expression ratios between LPA2 or LPA3 and Bcl- 2,and a significant negative correlation between LPA2 or LPA3 and Bax was found( r =0. 308, P 〈0.01; r =-0. 369., P 〈0.05) in patients with cancer. Conclusion LPA and its receptors may play an important role in the ovarian cancer; LPA2 and LPA3 maybe involved in Bcl-2 and Bax expression mediated by LPA signals in human ovarian oncogenesis. LPA changed the ratios of Bcl- 2/Bax though LPA receptors,which inhibited the apoptosis of ovarican cell and promoted ovarian cancer progression.
出处 《河北医科大学学报》 CAS 2008年第5期677-680,共4页 Journal of Hebei Medical University
基金 国家自然科学基金资助项目(30572093) 河北省科学技术研究及发展计划指导性项目(C2007001059)
关键词 卵巢肿瘤 受体 溶血磷脂酸 基因 BCL-2 ovarian neoplasms receptors, lysophosphatidic acid genes, bcl-2
  • 相关文献

参考文献9

  • 1Schwartz BM, Hong G, Morrison BH,et al. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells [J]. Gynecol Oncol, 2001,81 (2) : 291-300.
  • 2Hu YL, Tee MK, Goetzl EJ, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells [J]. J Natl Cancer Inst, 2001,93 (10) :762-768.
  • 3Im DS, Heise CE, Harding MA, et al. Molecular cloning and characterization of a lysophosphatidic acid receptor, EdgT, expressed in prostate[J]. Mol Pharmacol, 2000, 57 (A): 753- 759.
  • 4Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers[J]. JAMA, 1998,280(4) : 719-723.
  • 5Sengupta S,Xiao YJ,Xu Y. A novel lamin induced LPA autocrine loop in the migration of ovarian cancer cells[J]. FASEB J,2003,17(6) :1570-1572.
  • 6Chou CH, Wei LH, Kuo ML, et al. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/ NF-κB pathway by lysophosphatidic acid, an ovarian canceractivating factor[J]. Carcinogenesis, 2005,26 (1) : 45-52.
  • 7Goetzl EJ, Lee H,Azumi T,et al. Gelsolin binding and cellular presentation of lysophosphatidic acid [J]. J Biol Chem, 2000, 275(19) : 14573-14578.
  • 8Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis [J]. Oncogene, 2003, 22 ( 53 ) : 8590- 8607.
  • 9Groeger AM,Esposito V,De Luca A,et al. Prognostic value of immunohistochemical expression of p53, Bax, Bc-2 and Bcl-xL in resected non-small-cell lung cancers [J]. Histopathology, 2004,44(1) :54-63.

同被引文献101

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部